Crossmark

Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic

Crossref DOI link: https://doi.org/10.1016/j.rceng.2021.04.002

Published Print: 2022-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Patoulias, D.

Boulmpou, A.

Imprialos, K.

Stavropoulos, K.

Papadopoulos, C.

Doumas, M.
License Information

Text and Data Mining valid from 2022-04-01
More Information

This article is maintained by: Elsevier

Article Title: Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic

Journal Title: Revista Clínica Española (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rceng.2021.04.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rce.2021.04.001

Content Type: simple-article

Copyright: © 2021 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.

Document is current

Any future updates will be listed below